Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat - A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder

By Bymaster F.P.   Katner J.S.   Nelson D.L.   Hemrick-Luecke S.K.   Threlkeld P.G.   Heiligenstein J.H.   Morin S.M.   Gehlert D.R.   Perry K.W.  

Neuropsychopharmacology, Vol. 27, Iss. 5, 2002-11 ,pp. : 699-711

Elsevier

Access to resources Recommend Favorite

Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder

By Wilens T.E.  

Drugs, Vol. 63, Iss. 22, 2003-01 ,pp. : 2395-2411

Adis International

Access to resources Recommend Favorite

Stimulant Drug Effects on Attention Deficit/Hyperactivity Disorder: A Review of the Effects of Age and Sex of Patients

By  

Current Pharmaceutical Design, Vol. 16, Iss. 22, 2010-07 ,pp. : 2424-2433

Bentham Science Publishers

Access to resources Recommend Favorite

Comorbid Attention Deficit/Hyperactivity Disorder and Substance Use Disorder: Treatment Considerations

By  

Current Drug Abuse Reviews, Vol. 5, Iss. 3, 2012-09 ,pp. : 190-198

Bentham Science Publishers

Access to resources Recommend Favorite

OROS methylphenidate hydrochloride for adult patients with attention deficit/hyperactivity disorder

By McBurnett Keith   Starr H Lynn  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 315-324

Informa Healthcare

Access to resources Recommend Favorite